Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference

Apellis (Nasdaq: APLS) will participate in a webcast fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 9:50 a.m. ET.

Rhea-AI Summary

Apellis (Nasdaq: APLS) will participate in a webcast fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 9:50 a.m. ET.

The live webcast will be posted on the company’s Events and Presentations investor page and a replay will be available for approximately 30 days following the event.

Argus Feb 23 session

+0.85% close to close Open Argus

Details

News Market Reaction – APLS

In the Feb 23 session, APLS gained 0.85%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights another investor-facing appearance as Apellis engages at the TD Cowen c...

Analysis

This announcement highlights another investor-facing appearance as Apellis engages at the TD Cowen conference on March 2, 2026 at 9:50 a.m. ET, with a webcast replay available for 30 days. Set against recent clinical milestones, commercial updates, and frequent conference participation, it extends the company’s communication cadence. Investors monitoring the story may focus on how messaging at this event builds on prior Phase 3 data, market-share trends, and capital markets disclosures reported in recent months.

Key Figures

Conference date: March 2, 2026 Conference time: 9:50 a.m. ET Webcast replay period: 30 days

Conference date

March 2, 2026

TD Cowen 46th Annual Health Care Conference fireside chat

Conference time

9:50 a.m. ET

Scheduled start time of webcast fireside chat

Webcast replay period

30 days

Replay availability following the conference event

Historical Context

5 past events · Latest: Feb 19

5 events

1. Feb 19

   Scientific meeting data

   24h Move

   +1.9%

   Multiple Macula Society oral presentations including five-year GALE extension results.

2. Feb 10

   Earnings call scheduling

   24h Move

   -1.1%

   Announcement of Q4 and full-year 2025 earnings call and webcast logistics.

3. Jan 12

   Commercial update

   24h Move

   -15.0%

   Preliminary 2025 revenues, strong SYFOVRE uptake, EMPAVELI growth, and pipeline plans.

4. Jan 05

   Conference presentation

   24h Move

   -3.8%

   Planned J.P. Morgan Healthcare Conference presentation and webcast availability.

5. Dec 03

   Phase 3 trial results

   24h Move

   +2.9%

   Positive Phase 3 VALIANT outcomes for EMPAVELI in C3G and IC-MPGN published in NEJM.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in a webcast fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 9:50 a.m. ET.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 30 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.

Investor Contact:
Eva Stroynowski
ir@apellis.com
617.938.6229

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Apellis (APLS) present at the TD Cowen 46th Annual Health Care Conference?

Apellis (APLS) will present on Monday, March 2, 2026, at 9:50 a.m. ET. According to the company, the session is a webcast fireside chat posted live on the Events and Presentations investor page and available for replay after the event.

How can investors watch the Apellis (APLS) TD Cowen webcast on March 2, 2026?

Investors can watch the live webcast on the company's Events and Presentations investor page. According to the company, the webcast will be posted live and a replay will remain available for approximately 30 days after the event.

Will a replay of the Apellis (APLS) TD Cowen presentation be available and for how long?

Yes, a replay will be available for approximately 30 days following the event. According to the company, the replay will be posted on the Events and Presentations page of the investor website for on-demand viewing.

What format will Apellis (APLS) use for its March 2, 2026 TD Cowen presentation?

Apellis (APLS) will appear in a webcast fireside chat format at the conference. According to the company, the live session will be streamed on the investor Events and Presentations page and followed by a temporary replay period.

Where on the Apellis (APLS) website will the TD Cowen webcast be posted?

The webcast will be posted on the company's Events and Presentations page within the Investors and Media section. According to the company, that page will host the live stream and the replay for about 30 days after the event.